NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
Cognitive deficits associated with frontal lobe dysfunction are a determinant of long-term disability in schizophrenia and are not effectively treated with available medications. Clinical studies show that many aspects of these deficits are transiently induced in healthy individuals treated with N -methyl- d -aspartate (NMDA) antagonists. These findings and recent genetic linkage studies strongly implicate NMDA receptor deficiency in schizophrenia and suggest that reversing this deficiency is pertinent to treating the cognitive symptoms of schizophrenia. Despite the wealth of behavioral data on the effects of NMDA antagonist treatment in humans and laboratory animals, there is a fundamental lack of understanding about the mechanisms by which a general state of NMDA deficiency influences the function of cortical neurons. Using ensemble recording in freely moving rats, we found that NMDA antagonist treatment, at doses that impaired working memory, potentiated the firing rate of most prefrontal cortex neurons. This potentiation, which correlated with expression of behavioral stereotypy, resulted from an increased number of irregularly discharged single spikes. Concurrent with the increase in spike activity, there was a significant reduction in organized bursting activity. These results identify two distinct mechanisms by which NMDA receptor deficiency may disrupt frontal lobe function: an increase in disorganized spike activity, which may enhance cortical noise and transmission of disinformation; and a decrease in burst activity, which reduces transmission efficacy of cortical neurons. These findings provide a physiological basis for the NMDA receptor deficiency model of schizophrenia and may clarify the nature of cortical dysfunction in this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rats treated with NMDAR antagonists, PFC neurons display the elevated and irregular spiking activity and the reduced coordinated burst firing, suggesting that NMDA hypofunction in PFC may drive disorganized network activity 174.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [174]
In the citing paper
“In rats treated with NMDAR antagonists, PFC neurons display the elevated and irregular spiking activity and the reduced coordinated burst firing, suggesting that NMDA hypofunction in PFC may drive disorganized network activity 174.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [174]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
An Integrative Theory of Prefrontal Cortex Function
Miller, E. K., & Cohen, J. D. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.167 · Cited by 12,803
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Cellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663
Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex
McCormick, D. A., Connors, B. W., Lighthall, J. W., & Prince, D. A. (1985) · Journal of Neurophysiology · doi:10.1152/jn.1985.54.4.782 · Cited by 1,933
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Self-citationGlutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Intrinsic firing patterns of diverse neocortical neurons
Connors, B. W., & Gutnick, M. J. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90185-d · Cited by 1,448
Research works printed but not linked: 3
- Abel, K. M., Allin, M. P., Kucharska-Pietura, K., David, A., Andrew, C., Williams, S., Brammer, M. J. & Phillips, M. L. (2003) NeuroReport 14, 387-389.12634489
- Grubb, B. D., Riley, R. C., Hope, P. J., Pubols, L. & Duggan, A. W. (1996) Neuroscience 74, 1077-1086.8895876
- Steriade, M., Amzica, F. & Contreras, D. (1994) Electroencephalogr. Clin. Neurophysiol. 90, 1-16.7509269
Cited by
Items 201–300 of 470
Ma, L., Skoblenick, K., Seamans, J. K., & Everling, S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1839-15.2015 · Cited by 36
Celada, P., Lladó-Pelfort, L., Santana, N., Kargieman, L., Troyano‐Rodriguez, E., Riga, M. S., & Artigas, F. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000643 · Cited by 36
Lee, Y. A., Poirier, P., Otani, S., & Goto, Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.039 · Cited by 36
Furth, K. E., McCoy, A. J., Dodge, C., Walters, J. R., Buonanno, A., & Delaville, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186732 · Cited by 35
Pietraszek, M., Michaluk, J., Romańska, I., Wąsik, A., Gołembiowska, K., & Antkiewicz‐Michaluk, L. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9097-y · Cited by 35
Amat-Foraster, M., Jensen, A. A., Plath, N., Herrik, K. F., Celada, P., & Artigas, F. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.022 · Cited by 36
Stevenson, C. W., Halliday, D. M., Marsden, C. A., & Mason, R. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.013 · Cited by 35
Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801
Scorza, M. C., Castañé, A., Bortolozzi, A. A., & Artigas, F. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.012 · Cited by 35
Honsberger, M. J., Taylor, J. R., & Corlett, P. R. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.009 · Cited by 34
Amat-Foraster, M., Celada, P., Richter, U., Jensen, A. A., Plath, N., Artigas, F., & Herrik, K. F. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107745 · Cited by 35
Locklear, M. N., Cohen, A. B., Jone, A., & Kritzer, M. F. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu222 · Cited by 35
Encoding of Spatio-Temporal Input Characteristics by a CA1 Pyramidal Neuron Model
Pissadaki, E. K., Sidiropoulou, K., Reczko, M., & Poirazi, P. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001038 · Cited by 34
López-Gil, X., Jiménez-Sánchez, L., Romón, T., Campa, L., Artigas, F., & Adell, A. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001064 · Cited by 33
Storm on predictive brain: A neurocomputational account of ketamine antidepressant effect
Bottemanne, H., Berkovitch, L., Gauld, C., Balcerac, A., Schmidt, L., Mouchabac, S., & Fossati, P. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105410 · Cited by 33
Cotterill, E., & Eglen, S. J. (2019) · Advances in neurobiology · doi:10.1007/978-3-030-11135-9_8 · Cited by 33
Extrasynaptic NMDA Receptors Bidirectionally Modulate Intrinsic Excitability of Inhibitory Neurons
Yao, L., Rong, Y., Ma, X., Li, H., Deng, D., Chen, Y., Yang, S., Peng, T., Ye, T., Liang, F., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2065-21.2022 · Cited by 32
Kim, Y., Matthews, M., & Moghaddam, B. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07371.x · Cited by 32
Self-citationGarst-Orozco, J., Malik, R., Lanz, T. A., Weber, M. L., Xi, H. S., Arion, D., Enwright, J. F., Lewis, D. A., O’Donnell, P., Sohal, V. S., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233895 · Cited by 32
Beneficial Effects of the NMDA Antagonist Ketamine on Decision Processes in Visual Search
Shen, K., Kalwarowsky, S., Clarence, W., Brunamonti, E., & Paré, M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6317-09.2010 · Cited by 32
Koola, M. M., Nikiforuk, A., Pillai, A., & Parsaik, A. K. (2018) · PubMed · Cited by 32
Ulivieri, M., Wierońska, J. M., Lionetto, L., Martinello, K., Cieślik, P., Chocyk, A., Curto, M., Menna, L. D., Iacovelli, L., Traficante, A., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa074 · Cited by 32
Reelin has a preventive effect on phencyclidine-induced cognitive and sensory-motor gating deficits
Ishii, K., Nagai, T., Hirota, Y., Noda, M., Nabeshima, T., Yamada, K., Kubo, K., & Nakajima, K. (2015) · Neuroscience Research · doi:10.1016/j.neures.2014.12.013 · Cited by 31
Mahdavi, A., Qin, Y., Aubry, A.-S., Cornec, D., Kulikova, S. P., & Pinault, D. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2020.04.029 · Cited by 31
Iro, C. M., Hamati, R., Mansari, M. E., & Blier, P. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab010 · Cited by 31
Amargós‐Bosch, M., Adell, A., & Artigas, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04532.x · Cited by 31
Katayama, T., Jodo, E., Suzuki, Y., Hoshino, K.-Y., Takeuchi, S., & Kayama, Y. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.007 · Cited by 30
Ketamine Alters Lateral Prefrontal Oscillations in a Rule-Based Working Memory Task
Ma, L., Skoblenick, K. J., Johnston, K., & Everling, S. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2659-17.2018 · Cited by 30
Scorza, M. C., Meikle, M. N., López‐Hill, X., Richeri, A., Lorenzo, D., & Artigas, F. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008432 · Cited by 30
Neural and neuronal discoordination in schizophrenia: from ensembles through networks to symptoms
Krajcovic, B., Fajnerova, I., Horacek, J., Kelemen, E., Kubik, S., Svoboda, J., & Stuchlik, A. (2019) · Acta Physiologica · doi:10.1111/apha.13282 · Cited by 29
Fitzgerald, P. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.01.057 · Cited by 30
A circuit mechanism for decision-making biases and NMDA receptor hypofunction
Cavanagh, S. E., Lam, N. H., Murray, J. D., Hunt, L. T., & Kennerley, S. W. (2020) · eLife · doi:10.7554/elife.53664 · Cited by 29
EEG 40 Hz Coherence Decreases in REM Sleep and Ketamine Model of Psychosis
Castro‐Zaballa, S., Cavelli, M., González, J., Nardi, A. E., Machado, S. E. D. C., Scorza, C., & Torterolo, P. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00766 · Cited by 29
Antenucci, N., D’Errico, G., Fazio, F., Nicoletti, F., Bruno, V., & Battaglia, G. (2024) · Schizophrenia · doi:10.1038/s41537-024-00447-3 · Cited by 29
Bardgett, M. E., Points, M., Kleier, J., Blankenship, M. L., & Griffith, M. S. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.07.004 · Cited by 29
Luthra, P. M., Barodia, S. K., & Raghubir, R. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.12.019 · Cited by 29
Hare, B. D., Pothula, S., Dileone, R., & Duman, R. S. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107947 · Cited by 28
Lengersdorf, D., Marks, D., Uengoer, M., Stüttgen, M. C., & Güntürkün, O. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00085 · Cited by 28
A Computational Model for Spatial Working Memory Deficits in Schizophrenia
Cano-Colino, M., & Compte, A. (2012) · Pharmacopsychiatry · doi:10.1055/s-0032-1306314 · Cited by 28
Guidi, M., Rani, A., Karic, S., Severance, B., Kumar, A., & Foster, T. C. (2015) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2015.07.015 · Cited by 28
Towards biologically constrained attractor models of schizophrenia
Stein, H., Barbosa, J., & Compte, A. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.10.013 · Cited by 28
Alam, M., Angelov, S. D., Stemmler, M., von Wrangel, C., Krauss, J. K., & Schwabe, K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.08.017 · Cited by 28
Jami, S. A., Cameron, S., Wong, J. M., Daly, E. R., McAllister, A. K., & Gray, J. A. (2021) · Journal of Neurophysiology · doi:10.1152/jn.00661.2020 · Cited by 27
Semantic priming and neurobiology in schizophrenia: A theoretical review
Almeida, V. N., & Radanovic, M. (2021) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2021.108058 · Cited by 27
Bardgett, M. E., Points, M., Ramsey-Faulkner, C., Topmiller, J., Roflow, J., McDaniel, T., Lamontagne, T., & Griffith, M. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301580 · Cited by 27
Abad-Perez, P., Payá, F. J. M., Martínez-Otero, L., Borrell, V., Redondo, R. L., & Brotons‐Mas, J. R. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.03.022 · Cited by 27
Deng, D., Masri, S., Yao, L., Ma, X., Cao, X., Yang, S., Bao, S., & Zhou, Q. (2020) · Scientific Reports · doi:10.1038/s41598-020-68652-5 · Cited by 26
Shaw, A. D., Muthukumaraswamy, S. D., Saxena, N., Sumner, R. L., Adams, N. E., Moran, R. J., & Singh, K. D. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117189 · Cited by 26
Stevenson, C. W., Halliday, D. M., Marsden, C. A., & Mason, R. (2007) · Synapse · doi:10.1002/syn.20414 · Cited by 27
Overstimulation of NMDA Receptors Impairs Early Brain Development in vivo
Aida, T., Ito, Y., Takahashi, Y. K., & Tanaka, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036853 · Cited by 27
Differential effects of NMDA receptor antagonism on spine density
Ruddy, R. M., Chen, Y., Milenkovic, M., & Ramsey, A. J. (2014) · Synapse · doi:10.1002/syn.21784 · Cited by 25
Gunasekaran, S., Jacob, R. S., & Omkumar, R. V. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109024 · Cited by 25
Ketamine's schizophrenia-like effects are prevented by targeting PTP1B
Qin, Z., Zhang, L., ZASLOFF, M. A., Stewart, A. F. R., & Chen, H. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105397 · Cited by 25
Frau, R., Fanni, S., Serra, V., Simola, N., Godar, S. C., Traccis, F., Devoto, P., Bortolato, M., & Melis, M. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.01.032 · Cited by 23
Kubík, Š., Buchtová, H., Valeš, K., & Stuchlík, A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00075 · Cited by 23
Ketamine Alters Outcome-Related Local Field Potentials in Monkey Prefrontal Cortex
Skoblenick, K. J., Womelsdorf, T., & Everling, S. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv128 · Cited by 23
Ruggiero, A., Heim, L. R., Susman, L., Hreaky, D., Shapira, I., Katsenelson, M., Rosenblum, K., & Slutsky, I. (2024) · Neuron · doi:10.1016/j.neuron.2024.10.014 · Cited by 23
Rampino, A., Taurisano, P., Fanelli, G., Attrotto, M., Torretta, S., Antonucci, L. A., Miccolis, G., Pergola, G., Ursini, G., Maddalena, G., et al. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.06.005 · Cited by 23
Gating Deficits in Model Networks: A Path to Schizophrenia?
Vogels, T. P., & Abbott, L. F. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-992130 · Cited by 23
Arco, A. D., Ronzoni, G., & Mora, F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2055-9 · Cited by 22
Cui, K., Yu, Z., Xu, L., Jiang, W., Wang, L., Wang, X., Zou, D., Gu, J., Gao, F., Zhang, X., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1001869 · Cited by 22
NMDA antagonist and antipsychotic actions in cortico-subcortical circuits
Kargieman, L., Santana, N., Mengod, G., Celada, P., & Artigas, F. (2008) · Neurotoxicity Research · doi:10.1007/bf03033805 · Cited by 22
Large, C. H., Bison, S., Sartori, I., Read, K. D., Gozzi, A., Quarta, D., Antolini, M., Hollands, E. C., Gill, C. H., Gunthorpe, M. J., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178475 · Cited by 22
Nowak, K., Meyza, K., Nikolaev, E., Hunt, M., & Kasicki, S. (2012) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2012-1894 · Cited by 21
Clinical overview of NMDA-R antagonists and clinical practice
Davoudian, P. A., & Wilkinson, S. T. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.04.004 · Cited by 21
Han, W., Wang, F., Qi, J., Wang, F., Zhang, L., Zhao, S., Song, M., Wu, C., & Yang, J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.038 · Cited by 21
Ferris, M. J., Milenkovic, M., Liu, S., Mielnik, C. A., Beerepoot, P., John, C. E., España, R. A., Sotnikova, T. D., Gainetdinov, R. R., Borgland, S. L., et al. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12594 · Cited by 21
Carli, M., Calcagno, E., Mainini, E., Arnt, J., & Invernizzi, R. W. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2066-6 · Cited by 20
Hunt, M. J., Garcia, R., Large, C. H., & Kasicki, S. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.04.009 · Cited by 20
Aguilar, D. D., Giuffrida, A., & Lodge, D. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115612239 · Cited by 20
Effects of Low Doses of Ketamine on Pyramidal Neurons in Rat Prefrontal Cortex
Shen, G., Han, F., & Shi, W. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.05.037 · Cited by 20
Haase, F., Singh, R., Gloss, B., Tam, P., & Gold, W. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911125 · Cited by 20
A Review of Glutamate Receptors II: Pathophysiology and Pathology
Rousseaux, C. G. (2008) · Journal of Toxicologic Pathology · doi:10.1293/tox.21.133 · Cited by 20
Tang, Y., Zhou, Q., Chang, M., Chekroud, A. M., Gueorguieva, R. V., Jiang, X., Zhou, Y., He, G. S., Rowland, M. A., Wang, D., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.041 · Cited by 20
Castañé, A., Artigas, F., & Bortolozzi, A. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1205-9 · Cited by 20
Paradoxical effects of very low dose MK-801
Tang, Y., Zou, H., Strong, J. A., Cui, Y., Xie, Q., Zhao, G., Jin, M., & Yu, L. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.016 · Cited by 20
Skoblenick, K. J., & Everling, S. (2014) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00519 · Cited by 19
Psychotomimetic effects of PCP, LSD, and Ecstasy: pharmacological models of schizophrenia?
Catts, V. S., & Catts, S. V. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511789977.011 · Cited by 19
Lutgen, V., Qualmann, K. J., Resch, J. M., Kong, L., Choi, S., & Baker, D. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2926-3 · Cited by 20
Stress and Sucrose Intake Modulate Neuronal Activity in the Anterior Hypothalamic Area in Rats
Mitra, A., Guèvremont, G., & Timofeeva, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156563 · Cited by 19
Rodermund, P., Westendorff, S., & Nieder, A. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2009-19.2019 · Cited by 19
Srivastava, R., Choudhury, P. K., Dev, S. K., & Rathore, V. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22902 · Cited by 19
Kim, W., Shin, J. J., Jeong, Y. J., Kim, K., Bae, J. W., Noh, Y. W., Lee, S., Choi, W., Paik, S., Jung, M. W., et al. (2022) · eLife · doi:10.7554/elife.74998 · Cited by 18
Shikanai, H., Hiraide, S., Kamiyama, H., Kiya, T., Oda, K., Goto, Y., Yanagawa, Y., Shimamura, K., Goda, Y., & Togashi, H. (2013) · Journal of Anesthesia · doi:10.1007/s00540-013-1722-5 · Cited by 18
Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex
Labonté, B., Bambico, F. R., & Gobbi, G. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0446-4 · Cited by 18
Qi, R., Li, J., Wu, X., Geng, X., Chen, N., & Yu, H. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0208-8 · Cited by 18
Kjærby, C., Hovelsø, N., Dalby, N. O., & Sotty, F. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00081.2017 · Cited by 18
Hervig, M. E.-S., Thomsen, M. S., Kalló, I., & Mikkelsen, J. D. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.07.028 · Cited by 19
Kim, S. H., Park, H. G., Kim, H., Ahn, Y. M., & Kim, Y. S. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991192 · Cited by 16
Ketamine: Leading us into the future for development of antidepressants
Carreno, F. R., Lodge, D. J., & Frazer, A. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112532 · Cited by 16
Galvin, V. C., Yang, S., Lowet, A. S., Datta, D., Duque, A., Arnsten, A. F. T., & Wang, M. (2021) · Current Research in Neurobiology · doi:10.1016/j.crneur.2021.100016 · Cited by 16
Translational psychiatry—light at the end of the tunnel
Jones, K., Menniti, F. S., & Sivarao, D. V. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12725 · Cited by 16
Ashabi, G., Sadat‐Shirazi, M., Khalifeh, S., Elhampour, L., & Zarrindast, M. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.01.020 · Cited by 16
Lewis, E. M., Spence, H. E., Akella, N., & Buonanno, A. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01747-9 · Cited by 15
Barlow, R. L., Dalley, J. W., & Pekcec, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4836-5 · Cited by 15
Glutamatergic Approaches to the Conceptualization and Treatment of Schizophrenia
Kantrowitz, J. T., & Javitt, D. C. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_3 · Cited by 15
Kaleb, K., Pedrosa, V., & Clopath, C. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109577 · Cited by 16
Duncan, N. W., Wiebking, C., Tiret, B., Marjańska, M., Hayes, D. J., Lyttleton, O., Doyon, J., & Northoff, G. (2013) · PLoS ONE · doi:10.1371/annotation/8a1feb12-d70a-4fb2-8dcb-a9cad56c3afd · Cited by 14
Rapanelli, M., Frick, L. R., Bernardez-Vidal, M., & Zanutto, B. S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.09.043 · Cited by 14
The contribution of gamma bursting to spontaneous gamma activity in schizophrenia
Spencer, K., Nakhnikian, A., Hirano, Y., & Levin, M. E. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1130897 · Cited by 13
Sensory encoding in Neuregulin 1 mutants
Barz, C. S., Bessaïh, T., Abel, T. G., Feldmeyer, D., & Contreras, D. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0955-x · Cited by 13
Metadata
- Authors
- Jackson, M. E., Homayoun, H., & Moghaddam, B.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Moghaddam, Bita
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-05-24
- Volume
- 101
- Issue
- 22
- Pages
- 8467-8472
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC420417
- OpenAlex
- W2042422960
- Cited by
- 430
- References
- 53
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 6 · 2023: 15 · 2022: 11 · 2021: 16 · 2020: 19 · 2019: 22 · 2018: 16 · 2017: 17 · 2016: 21 · 2015: 29 · 2014: 18 · 2013: 23 · 2012: 28
- FWCI
- 10.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- NMDA receptor hypofunction, NMDA receptor antagonists, prefrontal cortex, neuronal firing rate, working memory deficits, schizophrenia, frontal lobe dysfunction, behavioral stereotypy
- MeSH terms
- Action Potentials, Animals, Behavior, Dose-Response Relationship, Drug, Electrophysiology, Humans, Male, Synaptic Transmission, Neurons, Schizophrenia, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Rats, Sprague-Dawley, Prefrontal Cortex, Excitatory Amino Acid Antagonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.